Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qiuyi Choo

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Advanced Drug Delivery Reviews|June 22, 2019
Nanomedicines - Tiny particles and big challengesMargareth R C Marques, Qiuyi Choo, Mukul Ashtikar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2021
FDA Approval Summary: Nivolumab with Ipilimumab and Chemotherapy for Metastatic Non-small Cell Lung Cancer, A Collaborative Project Orbis ReviewPaz J Vellanki, Flora Mulkey, Adnan A Jaigirdar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2021
FDA Approval Summary: Osimertinib for Adjuvant Treatment of Surgically Resected Non-Small Cell Lung Cancer, a Collaborative Project Orbis ReviewAbigail L Koch, Paz J Vellanki, Nicole Drezner, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Advanced Drug Delivery Reviews|June 22, 2019
Nanomedicines - Tiny particles and big challengesMargareth R C Marques, Qiuyi Choo, Mukul Ashtikar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2021
FDA Approval Summary: Nivolumab with Ipilimumab and Chemotherapy for Metastatic Non-small Cell Lung Cancer, A Collaborative Project Orbis ReviewPaz J Vellanki, Flora Mulkey, Adnan A Jaigirdar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2021
FDA Approval Summary: Osimertinib for Adjuvant Treatment of Surgically Resected Non-Small Cell Lung Cancer, a Collaborative Project Orbis ReviewAbigail L Koch, Paz J Vellanki, Nicole Drezner, et al.
Pageof 1